8-K: Current report filing
Published on May 8, 1998
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) May 7, 1998
COMMONWEALTH BIOTECHNOLOGIES, INC.
(Exact Name of Registrant as Specified in Charter)
Virginia 001-13467 56-1641133
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
911 East Leigh Street, Suite G-19, Richmond, Virginia 23219
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (804) 648-3820
N/A
(Former Name or Former Address, if Changed Since Last Report)
Item 5. Other Events.
On May 7, 1998, the Registrant announced the appointment of former
Virginia Governor George Allen to its Board of Directors. A copy of the press
release relating to the announcement is attached as an exhibit hereto.
Item 7. Financial Statements and Exhibits.
(a) Financial Statements of Businesses Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
99.1 Press Release, dated May 7, 1998, announcing the
appointment of former Virginia Governor George Allen
to the Registrant's Board of Directors.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
COMMONWEALTH BIOTECHNOLOGIES, INC.
By: /s/ Robert B. Harris, Ph.D.
--------------------------
Robert B. Harris, Ph.D.
President
May 8, 1998
EXHIBIT INDEX
Number Description of Exhibit
- ------ ----------------------
99.1 Press Release, dated May 7, 1998, announcing the appointment
of former Virginia Governor George Allen to the Registrant's
Board of Directors.